Bevacizumab Plus Docetaxel and Doxorubicin in Treating Patients With Previously Untreated Inflammatory or Locally Advanced Stage IIB or Stage III Breast Cancer

This study has been completed.

Study NCT00021086 Information provided by National Cancer Institute (NCI)

First Received: July 11, 2001 Last Updated: February 6, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given